<h4>Background</h4>Hereditary breast cancer accounts for approximately 10% of all breast cancer cases, with germline BRCA2 pathogenic variants (PVs) being the most prevalent genetic alteration. This evidence concerns the gene BRCA2 and breast carcinoma.